These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14697960)

  • 1. Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit.
    Aggarwal A; Ong JP; Goormastic M; Nelson DR; Arroliga AC; Farquhar L; Mayes J; Younossi ZM
    Transplant Proc; 2003 Dec; 35(8):2998-3002. PubMed ID: 14697960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of liver transplantation outcome in patients with MELD Score > or = 30.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Meira-Filho SP; Rezende MB; Paes AT; Afonso RC
    Transplant Proc; 2008 Apr; 40(3):797-9. PubMed ID: 18455020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group.
    Showstack J; Katz PP; Lake JR; Brown RS; Dudley RA; Belle S; Wiesner RH; Zetterman RK; Everhart J
    JAMA; 1999 Apr; 281(15):1381-6. PubMed ID: 10217053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR; Al-Freah MA; Portal AJ; Sizer E; Bernal W; Auzinger G; Rela M; Wendon JA; Heaton ND; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 May; 16(5):668-77. PubMed ID: 20440776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
    Volk ML; Lok AS; Pelletier SJ; Ubel PA; Hayward RA
    Gastroenterology; 2008 Nov; 135(5):1568-74. PubMed ID: 19009713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
    Herden U; Grabhorn E; Briem-Richter A; Ganschow R; Nashan B; Fischer L
    Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allocation procedure has no impact on patient and graft outcome after liver transplantation.
    Mossdorf A; Kalverkamp S; Langenbrinck L; Ulmer TF; Temizel I; Neumann U; Heidenhain C
    Transpl Int; 2013 Sep; 26(9):886-92. PubMed ID: 23834494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PELD score and posttransplant outcome in pediatric liver transplantation: a retrospective study of 100 recipients.
    Bourdeaux C; Tri TT; Gras J; Sokal E; Otte JB; de Ville de Goyet J; Reding R
    Transplantation; 2005 May; 79(9):1273-6. PubMed ID: 15880084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 1999; ():23-34. PubMed ID: 11038623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved graft survival of pediatric liver recipients transplanted with pediatric-aged liver donors.
    McDiarmid SV; Davies DB; Edwards EB
    Transplantation; 2000 Nov; 70(9):1283-91. PubMed ID: 11087142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of critically-ill children after living-donor liver transplant.
    Elgendy H; El Moghazy WM; Nafady-Hego H; Uemoto S
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():100-7. PubMed ID: 25894136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P; Oberkofler CE; Béchir M; Müllhaupt B; Geier A; Raptis DA; Clavien PA
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.